Schrödinger is the scientific leader in developing state-of-the-art chemical simulation software for use in pharmaceutical, biotechnology, and materials research.

Our mission is to improve human health and quality of life by transforming the way therapeutics and materials are discovered.

Nov 26, 2025 · 難溶性薬物の放出メカニズムを解明する – ASD研究の新たなアプローチ | Modelling amorphous solid dispersion (ASD) release mechanisms OCT 15, 2025 | AbbVie と Schrödinger のエ …

Complete modeling environment for your molecular discoveryDiscover better quality molecules, faster Maestro is Schrödinger’s streamlined portal for access to state-of-the-art predictive computational …

We are leveraging our computational platform and massive computing power to advance our proprietary programs both independently and in collaboration with leading biotech and pharmaceutical companies.

Headquartered in New York City, Schrödinger has multiple offices around the world including the USA, the UK, Germany, India, and Japan.

Our physics-based computational platform integrates differentiated solutions for predictive modeling, data analytics, and collaboration to enable rapid exploration of chemical space.

Aug 14, 2025 · Founded in 1990, Schrödinger has approximately 800 employees operating from 15 locations globally. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, …

Get more from your ideas by harnessing the power of large-scale chemical exploration and accurate in silico molecular prediction.

Schrödinger’s collaborative leadership team is committed to achieving the best possible outcomes for our customers, partners, patients, and other stakeholders.